About Laserroptek
Laserroptek is a company based in Seongnam-si (South Korea) founded in 2000 by Chu Hong. Laserroptek operates in a competitive market with competitors including Reliant Technologies, Advalight, RA Medical systems, Stroma Medical Corp and Lutronic, among others.
- Annual Revenue$17.8 M (USD)-22.22as on Dec 31, 2025
- Net Profit-$7.44 M (USD)-1271.71as on Dec 31, 2025
- EBITDA-$7.11 M (USD)-862as on Dec 31, 2025
People of Laserroptek
1 people are tracked at Laserroptek (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chu Hong | Founder & CEO | Leadership |
Complete people profiles for Laserroptek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Laserroptek
Laserroptek is a publicly listed company on the KRX with ticker symbol 199550 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Feb 2024
- Listed onKRX: 199550
- Listed entityLaseroptek Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7199550005
- Share price3,245.00 KRW (+1.56% on the day) · 2026-10-08
- Market capitalisation48,169,451,098.00 KRW
- EPS (diluted, trailing year)-537.83 KRW
- Volume (last session)36,948
Financials of Laserroptek
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 25.70B KRW | -10.74B KRW | -10.27B KRW |
| 2024 | 33.04B KRW | -783.2M KRW | 1.35B KRW |
| 2023 | 34.35B KRW | 16.8M KRW | 5.81B KRW |
| 2022 | 30.05B KRW | 2.82B KRW | 3.63B KRW |
| 2021 | 18.65B KRW | -1.26B KRW | 1.44B KRW |
Detailed financial statements for Laserroptek
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Laserroptek
Laserroptek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reliant Technologies, Advalight, RA Medical systems, Stroma Medical Corp and Lutronic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reliant-tech.com | 2001 | Mountain View, United States | $37M | 30 | Laser technologies for aesthetic applications were developed. | |
| advalight.com | 2006 | Ballerup, Denmark | $30.07M | 40 | Solid-state lasers for dermatological applications are developed. | |
| ramed.com | 2002 | Carlsbad, United States | $24.29M | 14 | Excimer lasers for skin and vascular disease treatments are developed. | |
| stromamedical.com | 2009 | Laguna Beach, United States | $43.01M | – | Laser therapy to permanently change eye color | |
| lutronic.com | 1997 | Goyang, South Korea | – | – | Aesthetic and medical laser systems for skin treatments are developed. | |
| accureacne.com | 2015 | Boulder, United States | $24.71M | 10 | Developer of Laser system device for acne treatment | |
| quantasystem.com | 1985 | Samarate, Italy | – | – | Portfolio of laser based devices for surgery, aesthetics and art | |
| gmeonline.de | 2011 | Erlangen, Germany | $2.3M | 12 | Dermatological laser and light systems are developed and marketed. | |
| axisthree.com | 2003 | Belfast, United Kingdom | $5M | – | Offers aesthetic consultations using advanced 3D patient simulation technology. |
Detailed competitors of Laserroptek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Laserroptek
The website of Laserroptek (laseroptek.com) receives about 5.1K visits a month and ranks #1,707,661 among all websites worldwide, #7,180 in Search Engines.
- Monthly visits5.1K
▼ 51.9% vs previous month
- Unique visitors4.8K
per month
- Global rank#1,707,661
among all websites
- Category rank#7,180
Computers Electronics and Technology · Search Engines
- Bounce rate24%
- Pages per visit3.2
- Average visit49 sec
- DevicesDesktop 33% · Mobile 67%
Websites whose visitors overlap most with Laserroptek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| naver.com | 100% | 1.6B | #20 | View details | |
| google.com | 96% | 85.8B | #1 | View details | |
| dropbox.com | 63% | 140.4M | #214 | View details |
Latest news on Laserroptek
Complete news archive for Laserroptek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Laserroptek
10 companies that operate in the same segment as Laserroptek (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Laserroptek
Laserroptek was founded in 2000.
Laserroptek is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Chu Hong is the current CEO of Laserroptek. They have also founded this company.
Annual revenue of Laserroptek is $17.8M as on Dec 31, 2025.
Laserroptek was founded in 2000 and is based in Seongnam-si, South Korea. Laser devices for aesthetic and dermal surgeries are produced by the company within the medical technology sector. Operations focus on systems such as an Alexandrite laser for even energy irradiation, a Q-Switched Nd:YAG laser offering twin and single pulses, and a solid-state UV laser utilizing a 311nm wavelength to address skin conditions.
Laserroptek's top competitors include Accure Acne, Reliant Technologies and Advalight.
Yes, Laserroptek is publicly traded on KRX under the ticker symbol 199550.
Laserroptek operates through Laser Optek Co., Ltd..